has been cited by the following article(s):
[1]
|
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome
JAMA Network Open,
2023
DOI:10.1001/jamanetworkopen.2022.55709
|
|
|
[2]
|
Testing equivalence of survival before but not after end of follow-up
Lifetime Data Analysis,
2021
DOI:10.1007/s10985-021-09517-5
|
|
|